Oxidative stress of the newborn in the pre- and postnatal period and the clinical utility of melatonin

Eloisa Gitto, Salvatore Pellegrino, Placido Gitto, Ignazio Barberi, Russel J Reiter

Research output: Contribution to journalArticle

215 Citations (Scopus)

Abstract

Newborns, and especially those delivered preterm, are probably more prone to oxidative stress than individuals later in life. Also during pregnancy, increased oxygen demand augments the rate of production of reactive oxygen species (ROS) and women, even with normal pregnancies, experience elevated oxidative stress and lipid peroxidation compared with nonpregnant women. Also, there appears to be an increase in ROS generation in the placenta of pre-eclamptic women. In comparison with healthy adults, newborn infants have lower levels of plasma antioxidants such as vitamin E, β-carotene, and sulphydryl groups, lower levels of plasma metal binding proteins including ceruloplasmin and transferrin, and reduced activity of erythrocyte superoxide dismutase. This review summarizes conditions of newborns where there is elevated oxidative stress. Included in this group of conditions is asphyxia, respiratory distress syndrome and sepsis and the review also summarizes the literature related to clinical trials of antioxidant therapies and of melatonin, a highly effective antioxidant and free radical scavenger. The authors document there is general agreement that short-term melatonin therapy may be highly effective and that it has a remarkably benign safety profile, even when neonates are treated with pharmacological doses. Significant complications with long-term melatonin therapy in children and adults also have not been reported. None of the animal studies of maternal melatonin treatment or in postnatal life have shown any treatment-related side effects. The authors conclude that treatment with melatonin might result in a wide range of health benefits, improved quality of life and reduced healthcare costs and may help reduce complications in the neonatal period.

Original languageEnglish (US)
Pages (from-to)128-139
Number of pages12
JournalJournal of Pineal Research
Volume46
Issue number2
DOIs
StatePublished - Mar 2009

Fingerprint

Melatonin
Oxidative Stress
Newborn Infant
Antioxidants
Reactive Oxygen Species
Therapeutics
Systemic Inflammatory Response Syndrome
Pregnancy
Free Radical Scavengers
Ceruloplasmin
Asphyxia
Insurance Benefits
Carotenoids
Transferrin
Vitamin E
Health Care Costs
Placenta
Lipid Peroxidation
Superoxide Dismutase
Carrier Proteins

Keywords

  • Free radicals
  • Human
  • Melatonin
  • Newborn
  • Oxidative stress
  • Pre-eclampsia
  • Sepsis

ASJC Scopus subject areas

  • Endocrinology

Cite this

Oxidative stress of the newborn in the pre- and postnatal period and the clinical utility of melatonin. / Gitto, Eloisa; Pellegrino, Salvatore; Gitto, Placido; Barberi, Ignazio; Reiter, Russel J.

In: Journal of Pineal Research, Vol. 46, No. 2, 03.2009, p. 128-139.

Research output: Contribution to journalArticle

Gitto, Eloisa ; Pellegrino, Salvatore ; Gitto, Placido ; Barberi, Ignazio ; Reiter, Russel J. / Oxidative stress of the newborn in the pre- and postnatal period and the clinical utility of melatonin. In: Journal of Pineal Research. 2009 ; Vol. 46, No. 2. pp. 128-139.
@article{5f9439cdca5d42afb1492975b0334f49,
title = "Oxidative stress of the newborn in the pre- and postnatal period and the clinical utility of melatonin",
abstract = "Newborns, and especially those delivered preterm, are probably more prone to oxidative stress than individuals later in life. Also during pregnancy, increased oxygen demand augments the rate of production of reactive oxygen species (ROS) and women, even with normal pregnancies, experience elevated oxidative stress and lipid peroxidation compared with nonpregnant women. Also, there appears to be an increase in ROS generation in the placenta of pre-eclamptic women. In comparison with healthy adults, newborn infants have lower levels of plasma antioxidants such as vitamin E, β-carotene, and sulphydryl groups, lower levels of plasma metal binding proteins including ceruloplasmin and transferrin, and reduced activity of erythrocyte superoxide dismutase. This review summarizes conditions of newborns where there is elevated oxidative stress. Included in this group of conditions is asphyxia, respiratory distress syndrome and sepsis and the review also summarizes the literature related to clinical trials of antioxidant therapies and of melatonin, a highly effective antioxidant and free radical scavenger. The authors document there is general agreement that short-term melatonin therapy may be highly effective and that it has a remarkably benign safety profile, even when neonates are treated with pharmacological doses. Significant complications with long-term melatonin therapy in children and adults also have not been reported. None of the animal studies of maternal melatonin treatment or in postnatal life have shown any treatment-related side effects. The authors conclude that treatment with melatonin might result in a wide range of health benefits, improved quality of life and reduced healthcare costs and may help reduce complications in the neonatal period.",
keywords = "Free radicals, Human, Melatonin, Newborn, Oxidative stress, Pre-eclampsia, Sepsis",
author = "Eloisa Gitto and Salvatore Pellegrino and Placido Gitto and Ignazio Barberi and Reiter, {Russel J}",
year = "2009",
month = "3",
doi = "10.1111/j.1600-079X.2008.00649.x",
language = "English (US)",
volume = "46",
pages = "128--139",
journal = "Journal of Pineal Research",
issn = "0742-3098",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Oxidative stress of the newborn in the pre- and postnatal period and the clinical utility of melatonin

AU - Gitto, Eloisa

AU - Pellegrino, Salvatore

AU - Gitto, Placido

AU - Barberi, Ignazio

AU - Reiter, Russel J

PY - 2009/3

Y1 - 2009/3

N2 - Newborns, and especially those delivered preterm, are probably more prone to oxidative stress than individuals later in life. Also during pregnancy, increased oxygen demand augments the rate of production of reactive oxygen species (ROS) and women, even with normal pregnancies, experience elevated oxidative stress and lipid peroxidation compared with nonpregnant women. Also, there appears to be an increase in ROS generation in the placenta of pre-eclamptic women. In comparison with healthy adults, newborn infants have lower levels of plasma antioxidants such as vitamin E, β-carotene, and sulphydryl groups, lower levels of plasma metal binding proteins including ceruloplasmin and transferrin, and reduced activity of erythrocyte superoxide dismutase. This review summarizes conditions of newborns where there is elevated oxidative stress. Included in this group of conditions is asphyxia, respiratory distress syndrome and sepsis and the review also summarizes the literature related to clinical trials of antioxidant therapies and of melatonin, a highly effective antioxidant and free radical scavenger. The authors document there is general agreement that short-term melatonin therapy may be highly effective and that it has a remarkably benign safety profile, even when neonates are treated with pharmacological doses. Significant complications with long-term melatonin therapy in children and adults also have not been reported. None of the animal studies of maternal melatonin treatment or in postnatal life have shown any treatment-related side effects. The authors conclude that treatment with melatonin might result in a wide range of health benefits, improved quality of life and reduced healthcare costs and may help reduce complications in the neonatal period.

AB - Newborns, and especially those delivered preterm, are probably more prone to oxidative stress than individuals later in life. Also during pregnancy, increased oxygen demand augments the rate of production of reactive oxygen species (ROS) and women, even with normal pregnancies, experience elevated oxidative stress and lipid peroxidation compared with nonpregnant women. Also, there appears to be an increase in ROS generation in the placenta of pre-eclamptic women. In comparison with healthy adults, newborn infants have lower levels of plasma antioxidants such as vitamin E, β-carotene, and sulphydryl groups, lower levels of plasma metal binding proteins including ceruloplasmin and transferrin, and reduced activity of erythrocyte superoxide dismutase. This review summarizes conditions of newborns where there is elevated oxidative stress. Included in this group of conditions is asphyxia, respiratory distress syndrome and sepsis and the review also summarizes the literature related to clinical trials of antioxidant therapies and of melatonin, a highly effective antioxidant and free radical scavenger. The authors document there is general agreement that short-term melatonin therapy may be highly effective and that it has a remarkably benign safety profile, even when neonates are treated with pharmacological doses. Significant complications with long-term melatonin therapy in children and adults also have not been reported. None of the animal studies of maternal melatonin treatment or in postnatal life have shown any treatment-related side effects. The authors conclude that treatment with melatonin might result in a wide range of health benefits, improved quality of life and reduced healthcare costs and may help reduce complications in the neonatal period.

KW - Free radicals

KW - Human

KW - Melatonin

KW - Newborn

KW - Oxidative stress

KW - Pre-eclampsia

KW - Sepsis

UR - http://www.scopus.com/inward/record.url?scp=59149092032&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59149092032&partnerID=8YFLogxK

U2 - 10.1111/j.1600-079X.2008.00649.x

DO - 10.1111/j.1600-079X.2008.00649.x

M3 - Article

C2 - 19054296

AN - SCOPUS:59149092032

VL - 46

SP - 128

EP - 139

JO - Journal of Pineal Research

JF - Journal of Pineal Research

SN - 0742-3098

IS - 2

ER -